---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-042506"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2023-11-22T23:59:59+00:00"
generated_at: "2026-06-07T22:26:50.822817+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences receives Nasdaq deficiency notice for failing to meet minimum stockholders' equity requirement

## Summary
- Stockholders' equity reported $2,435,646 as of Sept 30, 2023, below $2,500,000 minimum.
- Company has until Jan 5, 2024 to submit a plan to regain compliance to Nasdaq.
- If plan accepted, Nasdaq may grant up to 180-day extension to regain compliance.
- Company does not meet alternative quantitative standards for continued listing.

## SEC filing metadata
- accession: 0001493152-23-042506
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2023-11-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315223042506/0001493152-23-042506-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315223042506/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-042506
- JSON: https://secwatch.observer/filing/0001493152-23-042506.json
- Plain text: https://secwatch.observer/filing/0001493152-23-042506.txt

## Key facts
- Listing & Compliance Notices
  Enveric Biosciences, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: least $2,500,000 (the “Stockholders’ Equity Requirement”). The Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2023, reported stockholders’ equity of $2,435,646. As of the date of this Current Report on Form 8-K, the Company does not have a market value of listed securities of $35 million, or net income from continued operations of
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315223042506/0001493152-23-042506-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.